Allogene Therapeutics, Inc.

ALLO · Healthcare

$1.99

Markedsværdi: 685.8M USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe Allogene Therapeutics, Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

GlobeNewswire3. sep. 2026, 12.00

Priothera Appoints Experienced Biotech Executive, Dr Nigel Clark, as Chief Business Officer to Lead Strategic Partnering for Mocravimod

MT Newswires2. sep. 2026, 12.45

Allogene Therapeutics CFO Geoffrey Parker to Retire

BioPharma Dive2. sep. 2026, 12.32

Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts

GlobeNewswire2. sep. 2026, 12.30

Allogene Therapeutics Announces Retirement of Chief Financial Officer Geoffrey Parker

GlobeNewswire31. aug. 2026, 12.30

Allogene Therapeutics Announces Participation in September Investor Conference